MedPath

The impact of a text based reminder service to perform pelvic floor muscle exercises on the incidence of post prostatectomy stress urinary incontinence

Not Applicable
Recruiting
Conditions
Stress urinary incontinence
prostate cancer
Renal and Urogenital - Other renal and urogenital disorders
Cancer - Prostate
Registration Number
ACTRN12620000953932
Lead Sponsor
Westmead Hospital - Department of Urology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
126
Inclusion Criteria

Men over the age of 30 with confirmed prostate cancer (any stage that’s eligible for surgery), informed consent and an active mobile telephone.

Exclusion Criteria

Participants who have pre-existing incontinence or an IPSS (International prostate symptom score) above 19 will be excluded. Participants without an active mobile phone,

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of post-prostatectomy incontinence will be measured by number of pads used, this information will be recorded by participants in the study diary,[Time it takes to reach zero pad usage measured at 2 weeks, 6 weeks and 3 months.]
Secondary Outcome Measures
NameTimeMethod
Daily adherence to pelvic floor muscle exercises will be assess using a participant diary and also a study-specific questionnaire (Exercise adherence rating scale)<br><br><br>[Six weeks and three months post-surgery];Motivation to perform pelvic floor exercise (Assessed using the incontinence treatment motivation questionnaire) and participant diary[Assessed at 6 weeks and 3 months post-surgery];Acceptance and tolerability of the text message service by participants as measure by a tolerability questionnaire (This questionnaire was designed specifically for the study)[3months post-surgery];To assess whether pre-operative perceptions effect post-operative outcomes with a readiness for surgery questionnaire (This questionnaire was specifically designed for the trial)[Assessed 2 weeks pre-operatively and at 3 months post-operatively]
© Copyright 2025. All Rights Reserved by MedPath